Home-based phototherapy in psoriasis
A home-based phototherapy option may be noninferior to office-based treatment in patients with psoriasis.
In a study published in JAMA Dermatology, researchers randomly assigned 783 patients aged 12 years and older with plaque or guttate psoriasis to receive either home-based or office-based ultraviolet B phototherapy for 12 weeks followed by a 12-week observation period.
Compared with those who received the office-based treatment, the patients who received the home-based treatment achieved greater levels of clear or almost clear skin and had better Dermatology Life Quality Index scores.
Further, the researchers found that the patients in the home-based treatment group were more likely to adhere to treatment compared with those in the office-based treatment group. The duration of response following treatment was comparable between both patient groups.
The findings suggested that the home-based treatment approach may increase access to care among patients with plaque or guttate psoriasis.
Read more: JAMA Dermatology
The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.